ADCYAP1 and Huntington disease: As an important reduction of PAC1R protein levels is detected in the motor cortex and as dysregulation of corticostriatal pathway is a main event in the HD motor dysfunction (Bunner and Rebec, 2016), it is tentative to suggest that PACAP administration also promotes an effect on motor cortex, and therefore, the corticostriatal pathway.